Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    19092145 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin;   Drug: Glimepiride;   Drug: Rosiglitazone;   Drug: Metformin
2 Completed FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Condition: Type 2 Diabetes
Interventions: Drug: "GLIPULIN:" [insulin glargine, metformin, exenatide (GLP-1-agonist)];   Drug: Insulin glargine, metformin, prandial insulin

Indicates status has not been verified in more than two years